中国P站

Insights in Gynecologic Oncology
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Hormonal Therapy for Ovarian Cancer: Evolving Strategies

Dr. Lucas Taylor*
Stanford University School of Medicine, USA
*Corresponding Author: Dr. Lucas Taylor, Stanford University School of Medicine, USA, Email: lucas.taylor@yahoo.com

Received Date: Jun 04, 2025 / Published Date: Jun 30, 2025

Citation: Taylor DL (2025) Hormonal Therapy for Ovarian Cancer: Evolving Strategies. Current Trends Gynecol Oncol 10: 279

Copyright: 漏 2025 Dr. Lucas Taylor This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Hormonal therapy represents a developing avenue for ovarian cancer management, primarily for ER-positive tumors. Though limited by modest efficacy and resistance, research into novel agents and strategies targeting estrogen signaling is ongoing to enhance patient outcomes

International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.